Dear Customer,
Product Discontinuation Notice
after careful consideration, QIAGEN has decided to discontinue the production of the aLF Reader with May 30, 2021 as final date of order placement and June 30, 2021 as final date of delivery. We will continue to provide lifecycle and service support until June 30, 2026.
While we regret any inconvenience this announcement may cause, we are pleased to supply you with alternate reader solutions for rapid testing from our subsidiary company DIALUNOX GmbH. Feel free to contact us for further questions.
aLF - a open platform concept for lateral flow tests
How does it work?
aLF stands for “automated lateral flow testing“, a new business model for reader-based measurement of lateral flow tests.
While most vendors offer closed platforms with their own reader and a limited amount of tests, we have decided to offer a single device that is capable of processing many different tests from a range of manufacturers. You, as a user, have the choice to select your tests from a permanently growing number that better fit your needs and ensure you only need one reader in your lab.
What tests can be run?
Since aLF is an IVD platform, we only offer tests that have been validated on this platform. All tests on our list are proven to give reliable and precise results on the aLF Reader, so that you can immediately integrate them into your diagnostic workflow.